747 Protein Engineering III: Therapeutics

Thursday, November 12, 2015: 3:15 PM - 5:45 PM
151A/B (Salt Palace Convention Center)

This session will focus on protein engineering for therapeutic applications, with an emphasis on engineering peptides, antibodies, and other proteins with clinical relevance. Submissions with a broad range of applications, including cell targeting, imaging, therapeutics, and immunology, are encouraged.

Amy J. Karlsson Email: ajkarl@umd.edu
Jeffrey Rice Email: jrice@tntech.edu
- indicates paper has an Extended Abstract file available on CD.

3:55 PM
(747c) Protease-Activatable Viruses for Cardiovascular Disease Therapy
Michelle L. Ho, Momona Yamagami, Michael Lam, Veronica Gough and Junghae Suh

4:55 PM

See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division